Medivir: Birinapant is given attention at ASCO
Research Note
2019-05-16
11:10
Results from the completed Phase I combination study with birinapant and Keytruda will be presented during the ASCO conference in Chicago. The abstract released last night confirms what has previously been announced from Medivir.
KP
Klas Palin
Disclosures and disclaimers